What Genetic Discovery May Improve Hepatitis C Treatment?
Genetic Discovery May Improve Hepatitis C Treatment Finding will help predict patient response to therapy, researchers say Posted August 17, 2009 MONDAY, Aug. 17 (HealthDay News) — The first biomarker that predicts a patient’s response to hepatitis C treatments has been identified by U.S. researchers. The new marker is a single letter change — a C instead of a T — in a segment of DNA near the IL28B gene, according to the Duke University Medical Center team. They found it by studying the DNA of 1,671 people taking part in a study of hepatitis C treatments. Not only does this biomarker predict who is most likely to respond to treatment and who isn’t, it may solve the long-standing question of why responses to hepatitis C treatments vary so widely among racial and ethnic groups. Sources: http://health.usnews.com/articles/health/healthday/2009/0